ARCT
Arcturus Therapeutics Holdings Inc.
NASDAQ · Healthcare · Biotechnology · US
$16.03
−5.32%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 26.50x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.65x
- Price / sales
- 19.14x
- Price / cash flow
- -6.26x
Enterprise value
- Enterprise value
- $287.1M
- EV / sales
- 12.06x
- EV / EBITDA
- -3.46x
- EV / EBIT
- -2.78x
- Market cap
- $455.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026